Immunological Analysis of Treatment Interruption After Early Highly Active Antiretroviral Therapy

Ingrid M. M. Schellens, Katalin Pogany, Geertje H. A. Westerlaken, José A. M. Borghans, Frank Miedema, Irene G. M. van Valkengoed, Frank P. Kroon, Joep M. A. Lange, Kees Brinkman, Jan M. Prins, Debbie van Baarle

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)

Abstract

We longitudinally evaluated HIV-specific T-cell immunity after discontinuation of highly active antiretroviral therapy (HAART). After treatment interruption (TI), some individuals could maintain a low plasma viral load ( <15,000 copies/mL), whereas others could not (>50,000 copies/mL). Before HAART was initiated, plasma viral load was similar. After TI, the numbers of CD8(+) T cells increased more in individuals without viral control, whereas individuals maintaining a low viral load showed a more pronounced increase in HIV-specific CD8(+) T-cell numbers. No differences were seen in the number or percentage of cytokine-producing HIV-1-specific CD4(+) T cells, or in proliferative capacity of T cells. Four weeks after TI, the magnitude of the total HIV-1-specific CD8(+) T-cell response (IFN-gamma(+) and/or IL-2(+) and/or CD107a(+)) was significantly higher in individuals maintaining viral control. Degranulation contributed more to the overall CD8(+) T-cell response than cytokine production. Whether increased T-cell functionality is a cause or consequence of low viral load remains to be elucidated
Original languageEnglish
Pages (from-to)609-618
JournalViral immunology
Volume23
Issue number6
DOIs
Publication statusPublished - 2010

Cite this